Overview

Early Postpartum Intrauterine Device (IUD) Placement

Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
0
Participant gender:
Female
Summary
Women who have just given birth are at high risk for rapid repeat pregnancy, which can lead to negative consequences during the subsequent pregnancy. Providers have traditionally delayed starting birth control, especially placement of intrauterine devices (IUDs), post-delivery for a number of reasons. The first postpartum visit after a woman has given birth is typically scheduled for 6 weeks after her delivery, during which she is typically provided with her chosen method of birth control. This study will evaluate two different IUD placement times: 3 weeks and 6 weeks after delivery. This will allow the researchers to determine if placement time affects a woman's follow-through obtaining the IUD and keeping it inserted in place. The researchers will also look at bleeding patterns and patient/provider satisfaction with the IUD placement
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Society of Family Planning
Treatments:
Levonorgestrel
Criteria
Inclusion Criteria:

- Female

- 18 years or older

- Voluntarily requesting either copper T380A or levonorgestrel IUD placement for
postpartum contraception

- Within 5 days of vaginal or cesarean delivery of live born infant ≥32 0/7 weeks at the
time of enrollment

- English or Spanish speaking

- Able to give consent and agree to terms of the study

- No contraindications to use of either intrauterine device

Exclusion Criteria:

- Preterm delivery prior to 32 weeks gestation

- Recent pregnancy with multiple gestation

- Current incarceration

- Known congenital or acquired uterine anomaly, including fibroids that distort the
uterine cavity

- Current or recent pelvic infection (chorioamnionitis treated for fever in labor only
is not an exclusion)

- Suspected hypersensitivity or contraindication to the chosen IUD

- No insurance coverage for postpartum care, including Citizen Alien Waived Emergent
Medical (CAWEM)